DGX — Quest Diagnostics Incorporated · P/E 22, rev $5.94B

Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.

Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.

Use this DGX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the DGX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the DGX SEC filings page. Lician reads the product cache first so this HTML stays unique to Quest Diagnostics Incorporated even when a live quote feed is slow.

Quest Diagnostics Incorporated latest statements (FY2025)

Latest cached year on this hub. Full DGX income, balance, and cash tables.

  • Revenue$11.04B
  • Net Income$992.0M
  • Total Assets$16.23B
  • Total Debt$5.17B
  • Free Cash Flow$1.36B

DGX recent filings